Research Article
Clinical Survey of Decreased Blood Flow Rate in Continuous Renal Replacement Therapy: A Retrospective Observational Study
Table 3
Clinical factors associated with the development of decreased blood flow rate, evaluated by univariate Cox hazard regression analyses.
| | Univariate analysis | HR | 95% CI | value |
| Age | 1.01 | 0.99–1.03 | 0.48 | Male | 1.02 | 0.56–1.89 | 0.94 | Height | 1.01 | 0.99–1.04 | 0.30 | SOFA score | 1.03 | 0.95–1.11 | 0.52 | Sepsis or severe infectious diseases | 0.87 | 0.47–1.58 | 0.64 | Heart failure | 0.85 | 0.46–1.58 | 0.61 | Catheter position (jugular vein) | 0.64 | 0.30–1.36 | 0.24 | CVVHDF | 1.04 | 0.49–2.21 | 0.92 | ACT | 1.00 | 0.99–1.01 | 0.53 | Alb | 1.05 | 0.71–1.57 | 0.80 | Hb | 1.07 | 0.96–1.20 | 0.21 | Nephrologist inserted HD catheter | 0.93 | 0.54–1.62 | 0.80 | Physician (over 10 years of experience) inserted HD catheter | 1.24 | 0.71–2.14 | 0.44 |
|
|
ACT, activating coagulation time; Alb, albumin; CI, confidence interval; CVVHDF, continuous venovenous hemodiafiltration; Hb, hemoglobin; HD, hemodialysis; HR, hazard ratio; SOFA score, sequential organ failure assessment score.
|